287 related articles for article (PubMed ID: 18299495)
1. Association of activated vitamin D treatment and mortality in chronic kidney disease.
Kovesdy CP; Ahmadzadeh S; Anderson JE; Kalantar-Zadeh K
Arch Intern Med; 2008 Feb; 168(4):397-403. PubMed ID: 18299495
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical association between body mass index and mortality in men with CKD not yet on dialysis.
Kovesdy CP; Anderson JE; Kalantar-Zadeh K
Am J Kidney Dis; 2007 May; 49(5):581-91. PubMed ID: 17472839
[TBL] [Abstract][Full Text] [Related]
4. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study.
Tentori F; Albert JM; Young EW; Blayney MJ; Robinson BM; Pisoni RL; Akiba T; Greenwood RN; Kimata N; Levin NW; Piera LM; Saran R; Wolfe RA; Port FK
Nephrol Dial Transplant; 2009 Mar; 24(3):963-72. PubMed ID: 19028748
[TBL] [Abstract][Full Text] [Related]
5. Association of kidney function with mortality in patients with chronic kidney disease not yet on dialysis: a historical prospective cohort study.
Kovesdy CP; Trivedi BK; Anderson JE
Adv Chronic Kidney Dis; 2006 Apr; 13(2):183-8. PubMed ID: 16580621
[TBL] [Abstract][Full Text] [Related]
6. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort.
Levin A; Djurdjev O; Beaulieu M; Er L
Am J Kidney Dis; 2008 Oct; 52(4):661-71. PubMed ID: 18805347
[TBL] [Abstract][Full Text] [Related]
7. Association of low blood pressure with increased mortality in patients with moderate to severe chronic kidney disease.
Kovesdy CP; Trivedi BK; Kalantar-Zadeh K; Anderson JE
Nephrol Dial Transplant; 2006 May; 21(5):1257-62. PubMed ID: 16421161
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D treatment in chronic kidney disease.
Andress DL
Semin Dial; 2005; 18(4):315-21. PubMed ID: 16076355
[TBL] [Abstract][Full Text] [Related]
9. Association between body mass index and body fat in chronic kidney disease stages 3 to 5, hemodialysis, and peritoneal dialysis patients.
Leinig C; Pecoits-Filho R; Nascimento MM; Gonçalves S; Riella MC; Martins C
J Ren Nutr; 2008 Sep; 18(5):424-9. PubMed ID: 18721737
[TBL] [Abstract][Full Text] [Related]
10. Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up.
Devins GM; Mendelssohn DC; Barré PE; Taub K; Binik YM
Am J Kidney Dis; 2005 Dec; 46(6):1088-98. PubMed ID: 16310575
[TBL] [Abstract][Full Text] [Related]
11. Obesity is associated with secondary hyperparathyroidism in men with moderate and severe chronic kidney disease.
Kovesdy CP; Ahmadzadeh S; Anderson JE; Kalantar-Zadeh K
Clin J Am Soc Nephrol; 2007 Sep; 2(5):1024-9. PubMed ID: 17702720
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effects of better control of secondary hyperparathyroidism with paricalcitol in chronic dialysis patients.
Capuano A; Serio V; Pota A; Memoli B; Andreucci VE
J Nephrol; 2009; 22(1):59-68. PubMed ID: 19229819
[TBL] [Abstract][Full Text] [Related]
13. Effects of monthly dose and regular dosing of intravenous active vitamin D use on mortality among patients undergoing hemodialysis.
St Peter WL; Li S; Liu J; Gilbertson DT; Arneson TJ; Collins AJ
Pharmacotherapy; 2009 Feb; 29(2):154-64. PubMed ID: 19170585
[TBL] [Abstract][Full Text] [Related]
14. Does treatment with calcitriol improve survival in predialysis patients with chronic kidney disease?
Patel TV; Singh AK
Nat Clin Pract Endocrinol Metab; 2008 Sep; 4(9):484-5. PubMed ID: 18607400
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of secondary hyperparathyroidism in dialysis patients].
Di Luca M
G Ital Nefrol; 2009; 26 Suppl 49():S36-48. PubMed ID: 19941277
[TBL] [Abstract][Full Text] [Related]
17. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
Bhuriya R; Li S; Chen SC; McCullough PA; Bakris GL
Am J Kidney Dis; 2009 Apr; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
[TBL] [Abstract][Full Text] [Related]
18. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
20. Activated injectable vitamin D and hemodialysis survival: a historical cohort study.
Teng M; Wolf M; Ofsthun MN; Lazarus JM; Hernán MA; Camargo CA; Thadhani R
J Am Soc Nephrol; 2005 Apr; 16(4):1115-25. PubMed ID: 15728786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
